No results found for “”
No results found for filter “”
-
Statements & press releases 03.08.20
Joint Statement on the Health Innovation Partnership Proposal
Impactful solutions for public health and sustainable healthcare systems have always been and will remain at the core of our industries’ mission
Read Article -
Blog articles 01.08.20
World Lung Cancer Day: Mission Not Yet Accomplished
Lung cancer outcomes have improved but there is still a long way to go. We, as leaders from different companies, are all engaged in researching and developing...
Read Article -
Statements & press releases 30.07.20
Nominations for the EURORDIS Black Pearl Awards 2021 are now open!
The winners will be selected by the EURORDIS Board of Directors in October 2020 and presented with their awards at an online ceremony next February to...
Read Article -
Blog articles 30.07.20
2020: A year like no other – and it’s only half time
Time to shed light on some highlights but also time to reflect about the coming six months in a new environment
Read Article -
Statements & press releases 29.07.20
EFPIA statement on the Court of Justice of the European Union decision on transatlantic data transfers...
Disruptions to flows of health data can jeopardise public health
Read Article -
Blog articles 28.07.20
World Hepatitis Day: Our Commitment to Viral Hepatitis Elimination (Guest blog)
A guest blog by Mike Elliott, Vice President, Medical Affairs, Europe, Gilead
Read Article -
Statements & press releases 23.07.20
Free trade agreement with MRA in the best interest of European pharma, says new research
New research published today outlines the importance of a free trade agreement with a mutual recognition agreement for the European pharmaceutical industry...
Read Article -
Statements & press releases 23.07.20
EFPIA Statement on EU4Health Budget cuts
The devastating effects on people and societies of COVID-19 has underlined that investment in our health systems is vital to prevent future health crises...
Read Article -
Blog articles 23.07.20
Elephants, fairness, and magic formulas in drug pricing (Guest blog)
About price, access and affordability
Read Article -
Blog articles 16.07.20
Europe’s COVID-19 response points the way to fighting AMR
Antimicrobial resistance: Perspectives from a pharmaceutical SME
Read Article -
Blog articles 16.07.20
Europe’s cancer battle has momentum – let’s build on it
EU institutions are stepping up the fight against cancer. The new ‘Challenge Cancer’ Intergroup can be a platform for the collaboration needed to positively...
Read Article -
Blog articles 16.07.20
How biotech SMEs adapted to COVID-19: An interview with Minoryx Therapeutics
As the pandemic threatened to disrupt key clinical trials, a small company responded swiftly to protect patients and keep rare diseases research on track...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 10.06.20
Connecting Healthcare Awards - Submission period extended
The new deadline is 30 September 2020
Read Article -
EFPIA News 23.04.20
Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines
A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease Control (ECDC) on the patient-level...
Read Article -
EFPIA News 22.04.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article -
EFPIA News 20.04.20
Exscalate4Cov project: Call for Collaboration by DG Connect
The European Commission (DG Connect) is looking for industry partners to join the Exscalate4Cov project, seeking to accelerate identification of medicines...
Read Article -
EFPIA News 08.04.20
Official Update on the Connecting Healthcare Awards
A special COVID-19 category now available
Read Article -
EFPIA News 05.03.20
Connecting Healthcare Awards 2020 – Apply Now
Turn the spotlight on collaborative projects that make a difference to patients across Europe
Read Article -
EFPIA News 05.03.20
EFPIA's input to the EU's Beating Cancer Plan Roadmap consultation
The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients.
Read Article -
EFPIA News 20.02.20
IMI opens registrations for a webinar on the Coronavirus Call
The Innovative Medicines Initiative to launch EUR 45 million Call for proposals on COVID-19 early March
Read Article -
EFPIA News 10.02.20
EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on Good Manufacturing Practice...
The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients to receive medicines and medical...
Read Article -
EFPIA News 26.09.19
A European Cancer Plan: Make it disruptive!
Cancer patient outcomes vary widely across Europe – the European Health Forum Gastein will explore how to bring the best care to all
Read Article -
EFPIA News 11.09.19
Mission Letter from EU President-elect Ursula von der Leyen to Stella Kyriakides, Commissioner-designate...
We look forward to working with Commissioner Kyriakides and her team, as well as colleagues in Member States to ensure access and availability of new treatments...
Read Article -
EFPIA News 25.07.19
Unleashing the potential of data to improve cancer care
Report from the Oncology Data Summit
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 03.08.20
Joint Statement on the Health Innovation Partnership Proposal
Impactful solutions for public health and sustainable healthcare systems have always been and will remain at the core of our industries’ mission
Read Article -
Statements & press releases 30.07.20
Nominations for the EURORDIS Black Pearl Awards 2021 are now open!
The winners will be selected by the EURORDIS Board of Directors in October 2020 and presented with their awards at an online ceremony next February to...
Read Article -
Statements & press releases 29.07.20
EFPIA statement on the Court of Justice of the European Union decision on transatlantic data transfers...
Disruptions to flows of health data can jeopardise public health
Read Article -
Statements & press releases 23.07.20
Free trade agreement with MRA in the best interest of European pharma, says new research
New research published today outlines the importance of a free trade agreement with a mutual recognition agreement for the European pharmaceutical industry...
Read Article -
Statements & press releases 23.07.20
EFPIA Statement on EU4Health Budget cuts
The devastating effects on people and societies of COVID-19 has underlined that investment in our health systems is vital to prevent future health crises...
Read Article -
Statements & press releases 09.07.20
Joint EFPIA-IFPMA Press Release Announcing the AMR Action Fund
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion. Partnership aims to bring...
Read Article -
Statements & press releases 03.07.20
EFPIA response to the consultation on the Pharmaceutical Strategy Roadmap
EFPIA and its members stand ready to work with all stakeholders to create medical innovation and facilitate sustainable access for all
Read Article -
Statements & press releases 02.07.20
Time to act together: patients wait more than 6 times longer for access to new medicines in neighboring...
The EFPIA Patients WAIT Survey and the EFPIA/CRA analysis should serve as a starting point for an informed discussion on the root causes of unavailability...
Read Article -
Statements & press releases 30.06.20
EFPIA announces new members at a critical time for European healthcare and the research-based industry...
EFPIA welcomes Stallergenes Greer Ltd and Gilead Sciences as new members of EFPIA, as well as 14 new SME members and 7 new Partners in Research
Read Article -
Statements & press releases 22.06.20
Preparing for a potential second COVID-19 wave
Joint statement by Medicines for Europe and EFPIA with A.T. Kearney
Read Article -
Statements & press releases 22.06.20
Time to step up investments in health systems: EFPIA statement on the EU4Health Programme
The COVID crisis has shown us the close link between health and wealth. This is the time to step up health investments in Europe
Read Article -
Statements & press releases 19.06.20
COVID-19 and Brexit - Protecting patients across Europe from pandemics
A group of 18 pan-European healthcare stakeholders launched the statement “COVID-19 and Brexit – Protecting patients across Europe from pandemics” which...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 01.08.20
World Lung Cancer Day: Mission Not Yet Accomplished
Lung cancer outcomes have improved but there is still a long way to go. We, as leaders from different companies, are all engaged in researching and developing...
Read Article -
Blog articles 30.07.20
2020: A year like no other – and it’s only half time
Time to shed light on some highlights but also time to reflect about the coming six months in a new environment
Read Article -
Blog articles 28.07.20
World Hepatitis Day: Our Commitment to Viral Hepatitis Elimination (Guest blog)
A guest blog by Mike Elliott, Vice President, Medical Affairs, Europe, Gilead
Read Article -
Blog articles 23.07.20
Elephants, fairness, and magic formulas in drug pricing (Guest blog)
About price, access and affordability
Read Article -
Blog articles 16.07.20
Europe’s COVID-19 response points the way to fighting AMR
Antimicrobial resistance: Perspectives from a pharmaceutical SME
Read Article -
Blog articles 16.07.20
Europe’s cancer battle has momentum – let’s build on it
EU institutions are stepping up the fight against cancer. The new ‘Challenge Cancer’ Intergroup can be a platform for the collaboration needed to positively...
Read Article -
Blog articles 16.07.20
How biotech SMEs adapted to COVID-19: An interview with Minoryx Therapeutics
As the pandemic threatened to disrupt key clinical trials, a small company responded swiftly to protect patients and keep rare diseases research on track...
Read Article -
Blog articles 10.07.20
IMI Impact: tackling antimicrobial resistance together
The Innovative Medicines Initiative is delivering fresh hope in the search for new antibiotics
Read Article -
Blog articles 09.07.20
Time to join forces: The industry in the lead of the fight against AMR (Guest blog)
Together, we must work to translate the current crisis into concrete action that will deliver solutions to address AMR.
Read Article -
Blog articles 07.07.20
Faster and better decisions: accelerating the digital transformation in the time of COVID-19
As the healthcare system evolves, we believe that Europe will need to encourage health data sharing, whilst respecting privacy and security and facilitate...
Read Article -
Blog articles 03.07.20
New approaches, new solutions to ensuring access to medicines
Finding solutions to delays and barriers to patients getting access to new treatments
Read Article -
Blog articles 30.06.20
Make the regulatory system fit for the future of medical innovation
The “new normal” in regulatory terms should aim at decreasing complexity while ensuring the quality, safety and efficacy of the medicines for patients...
Read Article